• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

4
1
1
1

COUNTRY

1

CATEGORIES

  • 5
  • 5
  • 2
  • 2

PRICE

7
9
9
13

PUBLISHED

1
1
11
13

PRODUCT TYPE

8
5

Search "Global Epilepsy Pipeline Highlights - 2014" returned 13 results.

PRODUCT TITLE
Epilepsy Pipeline Highlights - 2014 Update Epilepsy Pipeline Highlights - 2014 Update - Product Thumbnail Image

Epilepsy Pipeline Highlights - 2014 Update

The latest report Epilepsy Pipeline Highlights – 2014 Update, provides most up-to-date information on key pipeline molecules in the global Epilepsy market. It covers emerging therapies for Epilepsy...

May 2014
FROM

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis

PharmaPoint: Epilepsy - Global Drug Forecast and Market Analysis Summary Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven...

January 2013
FROM
Recent Developments in the CNS Drug Market Recent Developments in the CNS Drug Market - Product Thumbnail Image

Recent Developments in the CNS Drug Market

This report reviews the global market for CNS prescription drugs and recent developments within the marketplace, including collaborative agreements, recent clinical trial results and new product approvals...

October 2013
FROM

GW Pharmaceuticals plc (GWP) - Financial and Strategic SWOT Analysis Review

GW Pharmaceuticals plc (GWP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

March 2014
FROM

Catalyst Pharmaceutical Partners, Inc. (CPRX) - Financial and Strategic SWOT Analysis Review

Catalyst Pharmaceutical Partners, Inc. (CPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile...

April 2014
FROM

US CNS Disorders Drug Pipeline Insight 2014

The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. The numbers of CNS disorders have increased at an alarming rate, while the available...

August 2014
FROM

Ligand Pharmaceuticals, Inc. (LGND) - Financial and Strategic SWOT Analysis Review

Ligand Pharmaceuticals, Inc. (LGND) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

April 2014
FROM

Quest Diagnostics Incorporated (DGX) - Financial and Strategic SWOT Analysis Review

Quest Diagnostics Incorporated (DGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

May 2014
FROM

Supernus Pharmaceuticals, Inc. (SUPN) - Financial and Strategic SWOT Analysis Review

Supernus Pharmaceuticals, Inc. (SUPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been...

June 2014
FROM

Aeolus Pharmaceuticals, Inc. (AOLS) - Financial and Strategic SWOT Analysis Review

Aeolus Pharmaceuticals, Inc. (AOLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

March 2014
FROM

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

May 2014
FROM

The Neurotechnology Industry 2014 Report

Now in its 10th year, The Neurotechnology Industry 2014 Report is an expanded and updated 650 page report of brain and nervous system markets and treatments It is the only publication to provide a comprehensive...

July 2014
FROM

Global & USA Transdermal Drug Delivery Market to 2017

This is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies, and business and economic environments. The report is supported by 320 tables...

December 2014
FROM
Loading Indicator

Our Clients

Our clients' logos